Skip to content
value.today

Active Implants LLC

🇺🇸 Memphis, Tennessee, USAHealth CareFounded 2013
Total raised
$120 M
4 rounds on record
Latest round
$6 M
Jan 2022
First round on record
Aug 2013
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Active Implants LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2022$6 MNo. 4$2 to $10 million

Active Implants LLC: Raise no. 4, Jan 2022

Investors in this round

6 investors had bought by the notice of Feb 7, 2022: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Adam T. Klyce · Executive Officer
  • Erik W. Harris · Executive Officer
  • Henry Michael Klyce · Executive Officer, Director · Executive Chairman and Member of the Board of Managers of the Issuer
  • J. Michael Keenan · Executive Officer
  • Ryan W. Belaney · Executive Officer
  • Tim W. Rinks · Executive Officer
  • Charles W. Federico · Director · Member of the Board of Managers of the Issuer
  • Gary D. Henley · Director · Member of the Board of Managers of the Issuer
  • James D. Lackie · Director · Member of the Board of Managers of the Issuer
  • Spence T. Wilson, Jr. · Director · Member of the Board of Managers of the Issuer
  • Ted Davis · Director · Member of the Board of Managers of the Issuer
  • William T. Mays, Jr. · Director · Member of the Board of Managers of the Issuer
  • William W. Robinson · Director · Member of the Board of Managers of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Michael Keenan, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 7, 2022. Read the notice at the SEC.

debt, optionsSEC
Jan 2019$55 MNo. 3$50 to $250 million

Active Implants LLC: Raise no. 3, Jan 2019

Investors in this round

59 investors had bought by the notice of Sep 23, 2020: 59 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$55 M of $75 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$8,500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Adam T. Klyce · Executive Officer
  • Erik W. Harris · Executive Officer
  • Henry Michael Klyce · Executive Officer, Director · Member of the Board of Managers of the Issuer
  • J. Michael Keenan · Executive Officer
  • Richard Michael Treharne · Executive Officer
  • Ryan W. Belaney · Executive Officer
  • Ted Davis · Executive Officer, Director · Member of the Board of Managers of the Issuer
  • Tim W. Rinks · Executive Officer
  • Charles W. Federico · Director · Member of the Board of Managers of the Issuer
  • Gary D. Henley · Director · Member of the Board of Managers of the Issuer
  • James D. Lackie · Director · Member of the Board of Managers of the Issuer
  • Spence T. Wilson, Jr. · Director · Member of the Board of Managers of the Issuer
  • William T. Mays, Jr. · Director · Member of the Board of Managers of the Issuer
  • William W. Robinson · Director · Member of the Board of Managers of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Michael Keenan, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 23, 2020. Read the notice at the SEC.

debt, optionsSEC
Mar 2017$10 MNo. 2$10 to $50 million

Active Implants LLC: Raise no. 2, Mar 2017

Investors in this round

1 investor had bought by the notice of Mar 24, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $40 M offered; $30 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$4,200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Adam T. Klyce · Executive Officer
  • Henry Michael Klyce · Executive Officer, Director · Member of the Board of Managers of the Issuer
  • J. Michael Keenan · Executive Officer
  • Richard Michael Treharne · Executive Officer
  • Ted Davis · Executive Officer, Director · Member of the Board of Managers of the Issuer
  • Haynes T. Morris · Director · Member of the Board of Managers of the Issuer
  • James D. Lackie · Director · Member of the Board of Managers of the Issuer
  • Spence T. Wilson, Jr. · Director · Member of the Board of Managers of the Issuer
  • William T. Mays, Jr. · Director · Member of the Board of Managers of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Michael Keenan, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 24, 2017. Read the notice at the SEC.

equitySEC
Aug 2013$49 MNo. 1$10 to $50 million

Active Implants LLC: Raise no. 1, Aug 2013

Investors in this round

40 investors had bought by the notice of Sep 10, 2013: 38 accredited, 2 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$49 M of $66 M offered; $17 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Henry Michael Klyce · Executive Officer, Director · Member of the Board of Managers of the Issuer
  • J. Michael Keenan · Executive Officer
  • Lex Giltaij · Executive Officer
  • Richard Michael Treharne · Executive Officer
  • Haynes T. Morris · Director · Member of the Board of Managers of the Issuer
  • James D. Lackie · Director · Member of the Board of Managers of the Issuer
  • Spence T. Wilson, Jr. · Director · Member of the Board of Managers of the Issuer
  • William T. Mays, Jr. · Director · Member of the Board of Managers of the Issuer
  • Corporation Active Implants · Promoter · Manager and Member of the Issuer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Michael Keenan, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 10, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Active Implants LLC chose not to state its revenue in its newest notice of a funding round (Feb 2022).

    SEC Form D · Feb 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2022

That is all the official record says: Active Implants LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Active Implants LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 59 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Active Implants LLC
NameRoleNamed in
Adam T. KlyceExecutive officerFeb 2022
Erik W. HarrisExecutive officerFeb 2022
Henry Michael KlyceExecutive Chairman and Member of the Board of Managers of the IssuerFeb 2022
J. Michael KeenanExecutive officerFeb 2022
Ryan W. BelaneyExecutive officerFeb 2022
Tim W. RinksExecutive officerFeb 2022
Richard Michael TreharneExecutive officerSep 2020
Ted DavisMember of the Board of Managers of the IssuerSep 2020
Lex GiltaijExecutive officerSep 2013
Charles W. FedericoMember of the Board of Managers of the IssuerFeb 2022
Gary D. HenleyMember of the Board of Managers of the IssuerFeb 2022
Henry Michael KlyceExecutive Chairman and Member of the Board of Managers of the IssuerFeb 2022
James D. LackieMember of the Board of Managers of the IssuerFeb 2022
Spence T. Wilson, Jr.Member of the Board of Managers of the IssuerFeb 2022
Ted DavisMember of the Board of Managers of the IssuerFeb 2022
William T. Mays, Jr.Member of the Board of Managers of the IssuerFeb 2022
William W. RobinsonMember of the Board of Managers of the IssuerFeb 2022
Haynes T. MorrisMember of the Board of Managers of the IssuerMar 2017
Corporation Active ImplantsManager and Member of the IssuerSep 2013